Research Analysts’ Recent Ratings Changes for Siemens Healthineers (SHL)

Siemens Healthineers (ETR: SHL) has recently received a number of price target changes and ratings updates:

  • 10/3/2019 – Siemens Healthineers was given a new €35.00 ($40.70) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock.
  • 9/26/2019 – Siemens Healthineers was given a new €32.30 ($37.56) price target on by analysts at JPMorgan Chase & Co.. They now have a “sell” rating on the stock.
  • 9/20/2019 – Siemens Healthineers was given a new €38.50 ($44.77) price target on by analysts at Barclays PLC. They now have a “neutral” rating on the stock.
  • 9/19/2019 – Siemens Healthineers was given a new €32.30 ($37.56) price target on by analysts at JPMorgan Chase & Co.. They now have a “sell” rating on the stock.
  • 9/12/2019 – Siemens Healthineers was given a new €37.00 ($43.02) price target on by analysts at Morgan Stanley. They now have a “neutral” rating on the stock.
  • 8/29/2019 – Siemens Healthineers had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • 8/16/2019 – Siemens Healthineers was given a new €38.00 ($44.19) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 8/13/2019 – Siemens Healthineers was given a new €41.00 ($47.67) price target on by analysts at HSBC Holdings plc. They now have a “neutral” rating on the stock.
  • 8/9/2019 – Siemens Healthineers was given a new €35.00 ($40.70) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 8/9/2019 – Siemens Healthineers was given a new €37.00 ($43.02) price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
  • 8/8/2019 – Siemens Healthineers was given a new €34.00 ($39.53) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock.
  • 8/8/2019 – Siemens Healthineers was given a new €34.90 ($40.58) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.
  • 8/8/2019 – Siemens Healthineers was given a new €36.00 ($41.86) price target on by analysts at Royal Bank of Canada. They now have a “neutral” rating on the stock.

Shares of Siemens Healthineers stock opened at €36.37 ($42.28) on Friday. The company has a quick ratio of 0.87, a current ratio of 1.30 and a debt-to-equity ratio of 55.12. The company has a market cap of $36.22 billion and a PE ratio of 25.45. The business has a 50 day moving average of €35.69 and a 200 day moving average of €36.58. Siemens Healthineers AG has a 52 week low of €31.90 ($37.09) and a 52 week high of €39.21 ($45.59).

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Featured Article: Cash Flow Analysis in Stock Selection

Receive News & Ratings for Siemens Healthineers AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers AG and related companies with MarketBeat.com's FREE daily email newsletter.